COLORECTAL CANCER THERAPEUTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Colorectal Cancer Therapeutics Market, By Therapy Type (Chemotherapy (Alkylating Agents, Antimetabolites, and Others), Immunotherapy (Immune Checkpoint Inhibitors, Oncolytic Virus Therapy, and Others), Targeted Therapy, and Others), By Route of Administration (Oral, Intravenous, Intramuscular, Subcutaneous, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In: 30 Mar, 2026
Code: CMI7461
Page number: 167
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026-2033

Table of Contents (Version-2026)

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Colorectal Cancer Therapeutics Market, By Therapy Type
  - Colorectal Cancer Therapeutics Market, By Route of Administration
  - Colorectal Cancer Therapeutics Market, By Distribution Channel
  - Colorectal Cancer Therapeutics Market, Region
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
- Epidemiology
- Pipeline Analysis
Colorectal Cancer Therapeutics Market, By Therapy Type, 2021 - 2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Chemotherapy
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    - Alkylating Agents
    - Antimetabolites
    - Others
- Immunotherapy
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    - Immune Checkpoint Inhibitors
    - Oncolytic Virus Therapy
    - Others
- Targeted Therapy
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    - Monoclonal antibodies
    - Small molecule inhibitors
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Colorectal Cancer Therapeutics Market, By Route of Administration, 2021 - 2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Oral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Intravenous
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Intramuscular
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Subcutaneous
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Colorectal Cancer Therapeutics Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Colorectal Cancer Therapeutics Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
  - Market Share (%) Analysis, 2026,2028 & 2033, (USD Bn)
  - Market Y-o-Y Growth Analysis (%), 2022 - 2033, (USD Bn)
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, By Therapy Type, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, By Therapy Type, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
    - Brazil
    - Argentina
    - Mexico
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, By Therapy Type, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
    - Germany
    - U.K.
    - Spain
    - France
    - Italy
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, By Therapy Type, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, By Therapy Type, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
    - GCC Countries
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, By Therapy Type, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
  - Market Size and Forecast, By Country/Region, 2021 - 2033, (USD Bn)
    - South Africa
    - North Africa
    - Central Africa
Competitive Landscape
- Sanofi
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Bristol-Myers Squibb Company
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Bayer AG
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Ono Pharmaceutical Co. Ltd
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- ALX Oncology Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Daiichi Sankyo Company, Limited
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Pfizer Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Exelixis, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- SOTIO Biotech AG
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- AB Science
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- BioNTech SE
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Effector Therapeutics, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Treos Bio Limited
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now